Immunogenicity and safety of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine: a systematic review

被引：0
|
作者：
Jingjing Lv
Hui Wu
Junjie Xu
Jiaye Liu
机构：
[1] Shandong Provincial Key Laboratory of Infectious Disease Control and Prevention,Expanded Program Immunization Division of Shandong Provincial Center for Disease Control and Prevention
[2] Shenzhen University General Hospital,Nosocomial Infection Control Department
[3] Peking University,Clinical Research Academy, Peking University Shenzhen Hospital
[4] Shenzhen University Health Science Center,School of Public Health
来源：
Infectious Diseases of Poverty | / 11卷
关键词：
Homologous vaccination; Heterologous vaccination; COVID-19; Immunogenicity; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Immunogenicity and safety of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine: a systematic review
    Lv, Jingjing
    Wu, Hui
    Xu, Junjie
    Liu, Jiaye
    [J]. INFECTIOUS DISEASES OF POVERTY, 2022, 11 (01)
  • [2] Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial
    Liu, Xinxue
    Shaw, Robert H.
    Stuart, Arabella S. V.
    Greenland, Melanie
    Aley, Parvinder K.
    Andrews, Nick J.
    Cameron, J. Claire
    Charlton, Sue
    Clutterbuck, Elizabeth A.
    Collins, Andrea M.
    Dinesh, Tanya
    England, Anna
    Faust, Saul N.
    Ferreira, Daniela M.
    Finn, Adam
    Green, Christopher A.
    Hallis, Bassam
    Heath, Paul T.
    Hill, Helen
    Lambe, Teresa
    Lazarus, Rajeka
    Libri, Vincenzo
    Long, Fei
    Mujadidi, Yama F.
    Plested, Emma L.
    Provstgaard-Morys, Samuel
    Ramasamy, Maheshi N.
    Ramsay, Mary
    Read, Robert C.
    Robinson, Hannah
    Singh, Nisha
    Turner, David P. J.
    Turner, Paul J.
    Walker, Laura L.
    White, Rachel
    Nguyen-Van-Tam, Jonathan S.
    Snape, Matthew D.
    [J]. LANCET, 2021, 398 (10303): : 856 - 869
  • [3] Immunogenicity and Safety of Homologous and Heterologous Prime-Boost Immunization with COVID-19 Vaccine: Systematic Review and Meta-Analysis
    Cheng, Haoyue
    Peng, Zhicheng
    Si, Shuting
    Alifu, Xialidan
    Zhou, Haibo
    Chi, Peihan
    Zhuang, Yan
    Mo, Minjia
    Yu, Yunxian
    [J]. VACCINES, 2022, 10 (05)
  • [4] Immune response of heterologous versus homologous prime-boost regimens with adenoviral vectored and mRNA COVID-19 vaccines in immunocompromised patients
    Chu, Chang
    Schoenbrunn, Anne
    Fischer, Dorothea
    Liu, Yvonne
    Hocher, Johann-Georg
    Weinerth, Jutta
    Klemm, Kristin
    von Baehr, Volker
    Kraemer, Bernhard K.
    Elitok, Saban
    Hocher, Berthold
    [J]. FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [5] IMMUNOGENICITY AND SAFETY OF HETEROLOGOUS VERSUS HOMOLOGOUS PRIME-BOOST REGIMENS WITH ADENOVIRAL VECTORED AND MRNA SARS-COV-2 VACCINE IN LIVER TRANSPLANT RECIPIENTS
    Sriphoosanaphan, Supachaya
    Suksawatamnuay, Sirinporn
    Srisoonthorn, Nunthiya
    Siripon, Nipaporn
    Thaimai, Panarat
    Makhasen, Wanwisar
    Mungnamtrakul, Nawakodchamon
    Thanapirom, Kessarin
    Nonthasoot, Bunthoon
    Hansasuta, Pokrath
    Komolmit, Piyawat
    [J]. GASTROENTEROLOGY, 2022, 162 (07) : S1252 - S1252
  • [6] Safety and Immunogenicity of Homologous and Heterologous Adenoviral-Vectored and mRNA COVID-19 Vaccine Regimens in Radiotherapy Patients
    Prayongrat, Anussara
    Noppaving, Patjaya
    Chobarporn, Thitiporn
    Sudhinaraset, Natthinee
    Teeyapun, Nattaya
    Pakvisal, Nussara
    Jantarabenjakul, Watsamon
    Sophonphan, Jiratchaya
    Lertbutsayanukul, Chawalit
    Poovorawan, Yong
    [J]. VACCINES, 2023, 11 (07)
  • [7] Immunogenicity and safety of heterologous versus homologous prime-boost regimens with adenoviral vectored and mRNA SARS-CoV-2 vaccine in liver transplant recipients: a prospective study
    Sriphoosanaphan, Supachaya
    Suksawatamnuay, Sirinporn
    Srisoonthorn, Nunthiya
    Siripon, Nipaporn
    Thaimai, Panarat
    Makhasen, Wanwisar
    Mungnamtrakul, Nawakodchamon
    Thanapirom, Kessarin
    Nonthasoot, Bunthoon
    Hansasuta, Pokrath
    Komolmit, Piyawat
    [J]. JOURNAL OF HEPATOLOGY, 2022, 77 : S772 - S772
  • [8] Reactogenicity and immunogenicity of heterologous prime-boost immunization with COVID-19 vaccine
    Thuy Trang Nguyen
    Trang Ho Thu Quach
    Thanh Mai Tran
    Huynh Ngoc Phuoc
    Ha Thi Nguyen
    Tuong Kha Vo
    Giau Van Vo
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2022, 147
  • [9] Immunogenicity and safety of heterologous versus homologous prime-boost schedules with inactivated and adenoviral vectored SARS-CoV-2 vaccines - A prospective multi-center study
    Phuensan, Pawat
    Sirimongkolkasem, Jarongkorn
    Tantawichien, Terapong
    Phannajit, Jeerath
    Kerr, Stephen J.
    Hansasuta, Pokrath
    Chantharit, Prawat
    Wongsa, Adisorn
    Fuengfoo, Pusit
    Chittinandana, Anutra
    Vareesangthip, Kriengsak
    Chayakulkeeree, Methee
    Jangsirikul, Sureeporn
    Schmidt, Araya
    Wanvimonsuk, Kanyika
    Winichakoon, Poramed
    Kajeekul, Rattagan
    Prayoonwiwat, Wichai
    Rerknimitr, Rungsun
    [J]. HELIYON, 2024, 10 (01)
  • [10] Safety and immunogenicity of heterologous and homologous inactivated and adenoviral-vectored COVID-19 vaccine regimens in healthy adults: a prospective cohort study
    Wanlapakorn, Nasamon
    Suntronwong, Nungruthai
    Phowatthanasathian, Harit
    Yorsaeng, Ritthideach
    Vichaiwattana, Preeyaporn
    Thongmee, Thanunrat
    Auphimai, Chompoonut
    Srimuan, Donchida
    Thatsanatorn, Thaksaporn
    Assawakosri, Suvichada
    Kanokudom, Sitthichai
    Poovorawan, Yong
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (01)
12345